Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-17-000987
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-10 17:00:18
Reporting Period:
2017-01-06
Filing Date:
2017-01-10
Accepted Time:
2017-01-10 17:00:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX () 1231
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1015747 Joseph Lewis C/o Cay House P.o. Box N-7776
E.p. Taylor Drive Lyford Cay
New Providence C5
No No Yes No
1266427 M Ivan Lieberburg 11682 El Camino Real, Suite 320
San Diego CA 92130
No No Yes No
1465834 Neil Reisman 11682 El Camino Real, Suite 320
San Diego CA 92130
No No Yes No
1465835 Christopher Fuglesang 11682 El Camino Real, Suite 320
San Diego CA 92130
No No Yes No
1465836 Boxer Asset Management Inc. C/o Cay House P.o. Box N-7776
E.p. Taylor Drive Lyford Cay
New Providence C5
No No Yes No
1465837 Boxer Capital, Llc 11682 El Camino Real, Suite 320
San Diego CA 92130
No No Yes No
1465914 I. Aaron Davis 11682 El Camino Real, Suite 320
San Diego CA 92130
No No Yes No
1468223 Mva Investors, Llc 11682 El Camino Real, Suite 320
San Diego CA 92130
No No Yes No
1579826 W Rodney Lappe 4660 La Jolla Village Drive, Suite 500
San Diego CA 92121
No No Yes No
1663609 Bharatha Shehan Dissanayake 11682 El Camino Real, Suite 320
San Diego CA 92130
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-06 280,059 $5.60 1,037,994 No 4 P Direct
Common Stock Acquisiton 2017-01-06 6,104 $5.60 435,444 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to purchase) Acquisiton 2017-01-06 2,341,786 $5.60 2,341,786 $0.00
Common Stock Warrant (right to purchase) Acquisiton 2017-01-06 51,047 $5.60 51,047 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,341,786 2017-01-06 No 4 P Direct
51,047 2017-01-06 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 30,518 Direct
Common Stock 13,131 Direct
Common Stock 37,241 Direct
Common Stock 77,038 Direct
Common Stock 87,052 Direct
Footnotes
  1. These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. ("Braslyn"), (ii) Boxer Capital, (iii) Boxer Asset Management Inc. ("Boxer Management"), (v) MVA Investors, LLC ("MVA Investors"), (vi) Joe Lewis, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) Neil Reisman, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the "Boxer Group), and indirectly by Boxer Management and Messrs.
  2. (Continued from Footnote 1) Lewis, Fuglesang, Reisman, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital. Each of Messrs. Fuglesang, Reisman, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
  3. These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. Each of Messrs. Fuglesang, Reisman, Lieberburg, Dissanayake and Davis is a member of MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
  4. These securities are owned directly by Christopher Fuglesang, who may be deemed to be a member of the Boxer Group, and includes 11,436 shares received in connection with the pro rata distribution by Boxer Capital to its members on March 16, 2016 (the "Boxer Capital Pro Rata Distribution").
  5. These securities are owned directly by Neil Reisman, who may be deemed to be a member of the Boxer Group, and includes 4,921 shares received in connection with the Boxer Capital Pro Rata Distribution.
  6. These securities are owned directly by Ivan M. Lieberburg, who may be deemed to be a member of the Boxer Group, and includes 34,981 shares received in connection with the Boxer Capital Pro Rata Distribution.
  7. These securities are owned directly by Shehan B. Dissanayake, who may be deemed to be a member of the Boxer Group, and includes 28,869 shares received in connection with the Boxer Capital Pro Rata Distribution.
  8. These securities are owned directly by Aaron I. Davis, who may be deemed to be a member of the Boxer Group, and includes 32,622 shares received in connection with the Boxer Capital Pro Rata Distribution.
  9. The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock.